BBS Research Hub
Research
My Research
Ask My Research
Back to Research
AI Summary Available
Correction to "Setmelanotide in Bardet-Biedl Syndrome: A 52-Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort".
March 22, 2026
Save
View on PubMed
Plain-English Summary
No abstract available for this paper.
Paper Information
PubMed ID:
41866701
Added to database:
March 24, 2026